Literature DB >> 61028

Absence of binding of pancreatic and urinary kallikreins to alpha 2-macroglobulin.

E Vahtera, U Hamberg.   

Abstract

Pancreatic and urinary kallikreins failed to form the typical serine proteinase complex with alpha2M (alpha2-macroglobulin). Studies were performed to compare this with the binding of trypsin to alpha2M at various molar binding ratios, with the use of Sephadex G-200 gel filtration to separate free and alpha2M-bound enzyme fractions. The subunit conversion was totally absent with pancreatic kallikrein from lhich traces of a binding proteinase had been removed. The lack of binding is believed to be the result of the restricted specificity of the kallikreins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61028      PMCID: PMC1163886          DOI: 10.1042/bj1570521

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  The preparation and properties of two new chromogenic substrates of trypsin.

Authors:  B F ERLANGER; N KOKOWSKY; W COHEN
Journal:  Arch Biochem Biophys       Date:  1961-11       Impact factor: 4.013

2.  G. The relation of the fibrinolytic mechanism to other systems. Influences on the kinin system by proteolysis in plasma.

Authors:  U Hamberg
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-07-01

3.  Human alpha-2-macroglobulin, characterization and trypsin binding. Purification methods, trypsin and plasmin complex formation.

Authors:  U Hamberg; P Stelwagen; H S Ervast
Journal:  Eur J Biochem       Date:  1973-12-17

4.  [Purification and some characteristics of a kallikrein from swine serum].

Authors:  E Habermann; W Klett
Journal:  Biochem Z       Date:  1966-09-08

5.  [Preparation of individual human 2 -macroglobulins. Comparative chemical properties].

Authors:  J P Frénoy; E Razafimahaleo; R Bourrillon
Journal:  Clin Chim Acta       Date:  1972-11       Impact factor: 3.786

6.  Kallikrein from pig pancreas. Purification, separation of components A and B, and crystallization.

Authors:  C Kutzbach; G Schmidt-Kastner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-07

7.  The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases.

Authors:  Z Werb; M C Burleigh; A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

8.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

9.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

10.  Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Kallikreins and kinins: mediators in inflammatory joint disease?

Authors:  K Worthy; C D Figueroa; P A Dieppe; K D Bhoola
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

2.  Role of urinary alpha1-antitrypsin in Padutin (kallikrein) inactivation.

Authors:  W H Hörl; R M Schäfer; A Heidland
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Functionally active alpha2-macroglobulin and kinen release in synovial fluids of rheumatoid arthritis.

Authors:  U Hamberg; E Vahtera; L Moilanen
Journal:  Agents Actions       Date:  1978-01

4.  Interaction of urokinase with alpha2-macroglobulin investigated by isoelectric focusing. Evidence for non-specific dissociable binding.

Authors:  E Vahtera; U Hamberg
Journal:  Biochem J       Date:  1978-06-01       Impact factor: 3.857

5.  Identification of a new tissue-kallikrein-binding protein.

Authors:  J Chao; D M Tillman; M Y Wang; H S Margolius; L Chao
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.